EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience

Ricardo Martinez-Tenopala, Victor Gonzalez-Uribe, Carlos Andres Gomez-Nuñez, Jimena Prieto-Gomez, Maria Julia Rendon-Salazar, Tamara Hernandez-Hernandez, Cesar F Pozo Beltran, Christian R Alcocer-Arreguin, Paola de Baro Alvarez, Zaira S Mojica-Gonzalez

Journal of Allergy and Clinical Immunology: Global · 2026-01 · 5 (1) · 100606

DOI: 10.1016/j.jacig.2025.100606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2026-01. Verfasst von Ricardo Martinez-Tenopala und 9 weiteren Autor:innen. Beteiligte Einrichtung: AlergiaMx, Benito Juarez, Mexico City, Mexico. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of triple therapy with inhaled corticosteroids (ICSs), long-acting beta-agonists (LABAs), and long-acting muscarinic antagonists (LAMAs) is increasingly common in asthma management, particularly in patients with uncontrolled disease. However, real-world data from Latin-American settings are limited.

Objective

We sought to compare asthma control and exacerbation frequency among patients receiving ICS/LABA/LAMA versus ICS/LABA alone at steps 4 and 5 of the Global Initiative for Asthma guidelines in specialized centers in Mexico.

Methods

A cross-sectional observational study was conducted in 3 allergy and pulmonary clinics. Adult patients with asthma receiving maintenance therapy at Global Initiative for Asthma step 4 or 5 were recruited. Demographic, clinical, and spirometric data were collected. Asthma control was assessed using the asthma control test. Comparisons were made between patients receiving ICS/LABA/LAMA and those receiving ICS/LABA only. Ordinal logistic regression was used to identify predictors of asthma control.

Results

Among 279 patients (71% female; mean age, 51.4 ± 12.3 years), 79 received triple therapy. At step 4, ICS/LABA/LAMA users had better asthma control than those on ICS/LABA alone (P = .03). At step 5, ICS/LABA/LAMA users showed lower asthma control test scores and more frequent exacerbations (P < .05), likely reflecting greater baseline severity. At step 4, ICS/LABA/LAMA use was associated with better asthma control in the unadjusted analysis; however, this association was no longer statistically significant after adjustment in the ordinal logistic regression model.

Conclusions

ICS/LABA/LAMA may improve asthma control at step 4 but not at step 5, possibly due to more severe disease and previous use of biologics in the latter group. These findings highlight the need for tailored therapy and better phenotyping in severe asthma.

Schlagwörter

Stichwörter der Autor:innen

AsthmaLAMAasthma managementtriple therapy

Autor:innen und Institutionen

  • AlergiaMx, Benito Juarez, Mexico City, Mexico.
  • Facultad Mexicana de Medicina, Universidad La Salle Mexico, Tlalpan, Mexico City, Mexico.
  • Subdireccion de Enseñanza Y Calidad de La Secretaria de Salud de Baja California Sur, La Paz, Mexico.
  • Sin Alergia GDL, Guadalajara, Jalisco, Mexico.
  • Pathology & Immunohistochemistry Department, Hospital General de Mexico Dr. Eduardo Liceaga, Cuauhtemoc, Mexico City, Mexico.

Zitieren

APA

Martinez-Tenopala, R., Gonzalez-Uribe, V., Gomez-Nuñez, C. A., Prieto-Gomez, J., Rendon-Salazar, M. J., Hernandez-Hernandez, T., Pozo Beltran, C. F., Alcocer-Arreguin, C. R., de Baro Alvarez, P., & Mojica-Gonzalez, Z. S. (2026). The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience. Journal of Allergy and Clinical Immunology: Global, 5(1), 100606. https://doi.org/10.1016/j.jacig.2025.100606

Vancouver

Martinez-Tenopala R, Gonzalez-Uribe V, Gomez-Nuñez CA, Prieto-Gomez J, Rendon-Salazar MJ, Hernandez-Hernandez T, et al. The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience. Journal of Allergy and Clinical Immunology: Global. 2026;5(1):100606. doi:10.1016/j.jacig.2025.100606

BibTeX
@article{MartinezTenopala2026,
  author = {Martinez-Tenopala, Ricardo and Gonzalez-Uribe, Victor and Gomez-Nuñez, Carlos Andres and Prieto-Gomez, Jimena and Rendon-Salazar, Maria Julia and Hernandez-Hernandez, Tamara and Pozo Beltran, Cesar F and Alcocer-Arreguin, Christian R and de Baro Alvarez, Paola and Mojica-Gonzalez, Zaira S},
  title = {The use of triple therapy, ICS/LABA/LAMA, in the treatment of asthma: A real-life Latin-American specialized centers experience},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {100606},
  doi = {10.1016/j.jacig.2025.100606}
}
Kostenlos starten →